Urivarx
Natural health product licensed in Canada
- Licence holder
- Semprae Laboratories Inc.
- NPN or DIN-HM
- 80105083
- Status
- Active licence
- Licence date
- 9 October 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Crateva magna Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 3,000 mg | 120 mg | Not calculated |
| Lindera aggregata Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,500 mg | 150 mg | Not calculated |
| Equisetum arvense Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,500 mg | 150 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Cellulose microcristalline, farine de riz, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps reduce symptoms of overactive bladder such as daytime urinary frequency, urgency and nocturia (combination of Lindera aggregata, Equisetum arvense and Crateva magna). Helps improve symptoms of urinary incontinence (combination of Lindera aggregata, Equisetum arvense, and Crateva magna).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heartbeat and/or difficulty breathing.
Source
Official Health Canada record, licence 80105083
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.